+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity



A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity



Plos one 10(4): E0125704



We describe the production and characterization of human monoclonal antibodies (mAb) specific for the major hepatitis B virus (HBV) S protein. The mAbs, two IgG1κ and one IgG1λ, were secreted by B-cell clones obtained from peripheral blood mononuclear cells (PBMC) of one person convalescent from acute hepatitis B and one vaccinated individual. The former recognized a denaturation-insensitive epitope within the p24 protein whereas the latter recognized a denaturation-sensitive, conformational epitope located within the HBsAg common "a" determinant. This mAb, denominated ADRI-2F3, displayed a very high protective titer of over 43,000 IU/mg mAb and showed an extremely potent neutralizing activity in the in vitro model of HBV infection using primary hepatocytes from Tupaia belangeri as target. Recombinant variable heavy and light domain sequences derived from mAb ADRI-2F3 were cloned into eukaryotic expression vectors and showed identical fine specificity and 1 log10 higher titer than the original IgG1λ. It is envisaged that such mAb will be able to efficiently prevent HBV reinfection after liver transplantation for end-stage chronic HBV infection or infection after needle-stick exposure, providing an unlimited source of valuable protective anti-HBs antibody.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 057030083

Download citation: RISBibTeXText

PMID: 25923526


Related references

A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity. Mabs 5(6): 946-955, 2013

Safety and neutralizing activity against hepatitis b virus of a human mono clonal anti hepatitis b surface antigen antibody. Nichidai Igaku Zasshi 41(12): 1163-1172, 1982

Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg). Antiviral Research 144: 153-163, 2017

Complexes of hepatitis b surface antigen and monoclonal anti hepatitis b surface antigen elicit stronger antibody production in mice than hepatitis b surface antigen alone. Hepatology 4(5): 1064, 1984

A human-human hybridoma secreting anti-Pseudomonas aeruginosa exotoxin-A monoclonal antibody with highly potent neutralizing activity. Cytotechnology 3(1): 31-37, 1990

Generation of a neutralizing human monoclonal antibody Fab fragment to surface antigen 1 of Toxoplasma gondii tachyzoites. Infection and Immunity 79(1): 512-517, 2011

A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity. Research in Virology 142(4): 247-259, 1991

Correlation of the e antigen antibody system with intra hepato cellular hepatitis b core antigen and hepatitis b surface antigen in hepatitis b surface antigen positive acute and chronic liver diseases and healthy hepatitis b surface antigen carriers. Digestion 14(5/6): 488, 1976

Direct detection of hepatitis b virus dna in human serum of hepatitis b surface antigen positive hepatitis b e antigen positive and hepatitis b surface antigen positive anti hepatitis b e antigen antibody carriers by a simplified molecular hybridization test. Hepatology 2(5): 723, 1982

Human monoclonal antibody against Hepatitis B virus surface antigen. Official Gazette of the United States Patent and Trademark Office Patents 1240(2), 2000

Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor. Transfusion 52(9): 1999-2006, 2012

Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen. Proceedings of the National Academy of Sciences of the United States of America 90(7): 3014-3018, 1993

Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg). Antiviral Research 75(2): 113-120, 2007

Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen. Biochemical and Biophysical Research Communications 142(3): 805-812, 1987

Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees. Antiviral Research 79(3): 188-191, 2008